Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3883-3893

Bentham Science Publishers

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite

Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

By Milano Amalia   De Rosa Vincenzo   Iaffaioli Rosario Vincenzo   Caponigro Francesco  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

Signal Transduction Pathways of the Epidermal Growth Factor Receptor in Colorectal Cancer and their Inhibition by Small Molecules

By  

Current Medicinal Chemistry, Vol. 19, Iss. 33, 2012-11 ,pp. : 5735-5744

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?

By Fernandez-Patron Carlos  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 1, 2007-01 ,pp. : 97-104

NRC Research Press

Access to resources Recommend Favorite